DRUG
Bright Minds Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · CA
$65.60
−3.56%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-8.0%
Return on equity
-8.0%
Return on assets
-12.9%
Return on invested capital
0.00x
Asset turnover
-$18.1M
Cash from operations
$23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026